Immune Globulin Subcutaneous (Human), 20% Liquid

CSL Behring

HIZENTRA is an Immune Globulin Subcutaneous (Human) (IGSC), 20% Liquid indicated for the treatment of:

• Primary immunodeficiency (PI) in adults and pediatric patients 2 years of age and older.
• Maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

• Store the HIZENTRA prefilled syringe or vial in its original carton to protect it from light.
• When stored at room temperature (up to 25°C [77°F]), HIZENTRA is stable for up to 30 months, as indicated by the expiration date printed on the outer carton of the prefilled syringe or vial label.
• Do not shake the HIZENTRA prefilled syringe or vial.
• Do not freeze. Do not use product that has been frozen